NMA: Nonprescription Medicines Academy

Recent Self Care News

  • Prevalence of Knee Pain Increases

    An analysis of data from two community-based studies indicates a marked recent increase in the prevalence of knee pain and an increase in symptomatic knee osteoarthritis, suggesting a bigger burden of knee pain in our society than previously thought.

    January 26th, 2012

  • Quick Takes

    • Hepatitis B vaccination recommended for adult patients with diabetes
    • “Up and Away and Out of Sight” education program reminds parents and caregivers about safe medication storage
    • Monitoring the Future survey shows decrease in abuse of nonprescription cough and cold medications
    • Cochrane systematic review finds little evidence available for dry mouth therapies
    • National online survey reveals problems with parents’ approach to treating fever in children
    • Decreased blood pressure in patients with type 2 diabetes may not be treatment effect of cinnamon
    • Botanical shampoos and conditioners for head lice prevention profiled in The Wall Street Journal
    • Two deaths linked to use of tap water in neti pots

    January 24th, 2012

  • New Product Alerts

    • Axia3 ProDigestive Antacid
    • Vicks Behind Ear Thermometer

    January 24th, 2012

  • Patient Safety Alerts

    • FDA, FTC act to remove “homeopathic” HCG weight loss products from the market
    • FDA alerts public to new concentration of liquid acetaminophen for infants
    • Voluntary recall of Novartis products

    January 24th, 2012

  • Upcoming Health Observances

    • Heart Month
    • National Children’s Dental Health Month
    • National Wear Red Day

    January 24th, 2012

  • Repeated Supratherapeutic Doses of Acetaminophen Associated With Reduced Survival

    A large, single-center cohort study conducted in the United Kingdom found that patients who ingested two or more supratherapeutic doses of acetaminophen over a time interval greater than 8 hours (resulting in a cumulative dose >4 g/day) had reduced survival compared with patients who had taken a single intentional overdose.

    January 4th, 2012

  • Aspirin and Other Oral Antiplatelet Agents Contribute to Most Adverse-Event Hospitalizations for Older Patients

    Aspirin and other oral antiplatelet agents are among the four medications and medication classes implicated in two thirds of hospitalizations for adverse drug events among older Americans.

    January 4th, 2012

  • Updated Guidelines for Secondary Prevention Include Recommendations for Aspirin Therapy, Influenza Vaccination

    The 2011 update to the American Heart Association/American College of Cardiology Foundation guideline on secondary prevention for patients with coronary and other atherosclerotic vascular disease includes recommendations for daily aspirin therapy and annual influenza vaccine.

    January 4th, 2012

  • Omega-3 Fatty Acids Reduce Severe Arrhythmia-Related Events in Patients with Diabetes and a Previous Myocardial Infarction

    Low-dose supplementation of omega-3 fatty acids can reduce the incidence of ventricular arrhythmias and fatal myocardial infarction (MI) in high-risk patients with diabetes and a previous MI, based on a secondary analysis of data from the Alpha Omega Trial.

    January 4th, 2012

  • Study Supports Daily Aspirin Therapy for Patients with Hereditary Colorectal Cancer

    In the Colorectal Adenoma/carcinoma Prevention Programme 2 (CAPP-2) randomized trial, daily doses of aspirin 600 mg for a mean of 25 months substantially reduced cancer incidence in carriers of Lynch syndrome—the major form of hereditary colorectal cancer—at a mean follow-up of 55.7 months.

    January 4th, 2012